SCHEMBL6537504

SCHEMBL6537504

Nc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1-n1ccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ATR Q13535 2/20 0.44
JAK1 P23458 3/20 0.41
JAK2 O60674 3/20 0.40
TYK2 P29597 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC2 Q92769 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CRHBP P24387 1/20 0.38
HTT P42858 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537346 0.90 CYP3A4 (0.47) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537902 0.88 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8474859 0.88 CYP3A4 (0.52) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537955 0.87 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6538283 0.87 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537740 0.87 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6538094 0.86 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6538171 0.86 CYP3A4 (0.50) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537774 0.86 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537802 0.85 CYP3A4 (0.45) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed